Top of this page
Skip navigation, go straight to the content

Our Science Our clinical studies Seletracetam

Clinical Study Information - seletracetam

Disease area
studied
Abbreviated title Phase Study ID Registry database Study results Study summary Publication (if available)
Epilepsy Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures Phase 2 N01191
Completed
NCT00152451
Epilepsy Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam Phase 2 N01192
Completed
NCT00152503
Epilepsy Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy Phase 3 N01197
Terminated
NCT00175851
Epilepsy A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures Phase 2 N01272
Terminated
NCT00422110